Serum lipids and postprandial glucose and insulin levels in hyperlipidemic subjects after consumption of an oat β-glucan-containing ready meal

Annals of Nutrition and Metabolism

Volumn 52, Issue 2, 2008, Pages 83-90

  Biorklund M ^a   Holm, J ^b   Onning G ^a  

^a LUND UNIVERSITY   (Sweden)

^b Findus AB   (Sweden)

Author keywords

Glucan; Glucose; Hyperlipidemia; Insulin; Oats; Serum lipids

Indexed keywords

BETA GLUCAN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; PLACEBO;

ARTICLE; BODY WEIGHT; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIETARY INTAKE; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN EXPERIMENT; HYPERLIPIDEMIA; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LOW FAT DIET; MALE; NORMAL HUMAN; OAT; OUTCOME ASSESSMENT; POSTPRANDIAL STATE; PRIORITY JOURNAL; TEST MEAL;

ADULT; AGED; APOLIPOPROTEINS B; AVENA SATIVA; BETA-GLUCANS; BLOOD GLUCOSE; C-REACTIVE PROTEIN; CHOLESTEROL; CHOLESTEROL, HDL; CHOLESTEROL, LDL; DIETARY FIBER; DIETARY SUPPLEMENTS; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; INSULIN; INTERVENTION STUDIES; MALE; MIDDLE AGED; POSTPRANDIAL PERIOD; SATIATION; SINGLE-BLIND METHOD; TRIGLYCERIDES;

AVENA;

EID: 44249101469     PISSN: 02506807     EISSN: None     Source Type: Journal    
DOI: 10.1159/000121281     Document Type: Article

References (27)

1. Ripsin CM, Keenan JM, Jacobs DR Jr, Elmer PJ, Welch RR, Van Horn L, Liu K, Turnbull WH, Thye FW, Kestin M, Hegsted M, Davidson DM, Davidson MH, Dugan LD, Demark-Wahnefried W, Beling S: Oat products and lipid lowering. A meta-analysis. JAMA 1992;267:3317-3325.
2. Brown L, Rosner B, Willett WW, Sacks FM: Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am J Clin Nutr 1999;69:30-42.
3. Kerckhoffs DA, Brouns F, Hornstra G, Mensink RP: Effects on the human serum lipoprotein profile of β-glucan, soy protein and isoflavones, plant sterols and stanols, garlic and tocotrienols. J Nutr 2002;132:2494-2505.
4. Jenkins DJ, Kendall CW, Faulkner D, Vidgen E, Trautwein EA, Parker TL, Marchie A, Koumbridis G, Lapsley KG, Josse RG, Leiter LA, Connelly PW: A dietary portfolio approach to cholesterol reduction: combined effects of plant sterols, vegetable proteins, and viscous fibers in hypercholesterolemia. Metabolism 2002;12:1596-1604.
5. Anderson JW, Bridges SR: Hypocholesterolemic effects of oat bran in humans; in Wood PJ (ed): Oat Bran. St. Paul, American Association of Cereal Chemists, 1993, pp 139-157.
6. Wood PJ, Beer MU: Functional oat products; in Mazza G (ed): Functional Foods. Biochemical and Processing Aspects. Lancaster, Technomic Publishing, 1998, pp 1-37.
7. Malkki Y, Virtanen E: Gastrointestinal effects of oat bran and oat gum: a review. Lebensm Wiss Technol 2001;34:337-347.
8. Braaten JT, Wood PJ, Scott FW, Wolynetz MS, Lowe MK, Bradley-White P, Collins MW: Oat β-glucan reduces blood cholesterol concentration in hypercholesterolemic subjects. Eur J Clin Nutr 1994;48:465-474.
9. Bourdon I, Yokoyama W, Davis P, Hudson C, Backus R, Richter D, Knuckles B, Schneeman BO: Postprandial lipid, glucose, insulin, and cholecystokinin responses in men fed barley pasta enriched with β-glucan. Am J Clin Nutr 1999;69:55-63.
10. Dubois C, Armand M, Senft M, Portugal H, Pauli AM, Bernard PM, Lafont H, Lairon D: Chronic oat bran intake alters postprandial lipemia and lipoproteins in healthy adults. Am J Clin Nutr 1995;61:325-333.
11. Liljeberg HG, Granfeldt YE, Bjorck IM: Products based on high fiber barley genotype, but not on common barley or oats, lower postprandial glucose and insulin responses in healthy humans. J Nutr 1996;126:458-466.
12. Wursch P, Pi-Sunyer FX: The role of viscous soluble fiber in the metabolic control of diabetes. A review with special emphasis on cereals rich in β-glucan. Diabetes Care 1997;20:1774-1780.
13. Battilana P, Ornstein K, Minehira K, Schwarz JM, Acheson K, Schneiter P, Burri J, Jequier E, Tappy L: Mechanisms of action of β-glucan in postprandial glucose metabolism in healthy men. Eur J Clin Nutr 2001;55:327-333.
14. Wood PJ, Braaten JT, Scott FW, Riedel KD, Wolynetz MS, Collins MW: Effect of dose and modification of viscous properties of oat gum on plasma glucose and insulin following an oral glucose load. Br J Nutr 1994;72:731-743.
15. Wood PJ, Beer MU, Butler G: Evaluation of role of concentration and molecular weight of oat β-glucan in determining effect of viscosity on plasma glucose and insulin following an oral glucose load. Br J Nutr 2000;84:19-23.
16. Tappy L, Gugolz E, Wursch P: Effects of breakfast cereals containing various amounts of β-glucan fibers on plasma glucose and insulin responses in NIDDM subjects. Diabetes Care 1996;19:831-834.
17. Code of Federal Regulations: Food labeling: health claims; soluble fiber from whole oats and risk of coronary heart disease. Fed Regist 1997;62(21 CFR Part 101):15343-15344; http://www.cfsan.fda.gov/~lrd/fr970331.html.
18. Lyly M, Salmenkallio-Marttila M, Suortti T, Autio K, Poutanen K, Lähteenmäki L: The sensory characteristics and rheological properties of soups containing oat and barley β-glucan before and after freezing. Lebensm Wiss Technol 2004;37:749-761.
19. Biörklund M, van Rees A, Mensink RP, Önning G: Changes in serum lipids and postprandial glucose and insulin concentrations after consumption of beverages with β-glucans from oats or barley. A randomised dose-controlled trial. Eur J Clin Nutr 2005;59:1272-1281.
20. Friedewald WT, Levy RI, Fredrickson DS: Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 1972;1:499-502.
21. Suortti T, Johansson L, Autio K: Effect of heating and freezing on molecular weight of oat β-glucan. Annu Meet Am Assoc Cereal Chemists, 2000, abstract 332.
22. Onning G, Wallmark A, Persson M, Akesson B, Elmstahl S, Oste R: Consumption of oat milk for 5 weeks lowers serum cholesterol and LDL cholesterol in free-living men with moderate hypercholesterolemia. Ann Nutr Metab 1999;43:301-309.
23. Lovegrove JA, Clohessy A, Milon H, Williams CM: Modest doses of β-glucan do not reduce concentrations of potentially atherogenic lipoproteins. Am J Clin Nutr 2000;72:49-55.
24. Jenkins DJ, Kendall CW, Vuksan V, Vidgen E, Parker T, Faulkner D, Mehling CC, Garsetti M, Testolin G, Cunnane SC, Ryan MA, Corey PN: Soluble fiber intake at a dose approved by the US Food and Drug Administration for a claim of health benefits: serum lipid risk factors for cardiovascular disease assessed in a randomized controlled crossover trial. Am J Clin Nutr 2002;75:834-839.
25. Wolever TM, Jenkins DJ, Mueller S, Boctor DL, Ransom TP, Patten R, Chao ES, McMillan K, Fulgoni V 3rd: Method of administration influences the serum cholesterol-lowering effect of psyllium. Am J Clin Nutr 1994;59:1055-1059.
26. Hu FB, Willett WC: Optimal diets for prevention of coronary heart disease. JAMA 2002;288:2569-2578.
27. Jenkins DJ, Kendall CW, Vuksan V: Viscous fibers, health claims, and strategies to reduce cardiovascular disease risk. Am J Clin Nutr 2000;71:401-402.